The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $15.09

Today's change-0.77 -4.85%
Updated December 7 4:00 PM EST. Delayed by at least 15 minutes.
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $15.09

Today's change-0.77 -4.85%
Updated December 7 4:00 PM EST. Delayed by at least 15 minutes.

Endo International PLC down (U.S.)$0.77

Endo International PLC closed sharply lower Wednesday, dropping (U.S.)$0.77 or 4.85% to (U.S.)$15.09. Over the last five days, shares have lost 5.75% and are down 75.35% for the last year to date. This security has underperformed the S&P 500 by 82.60% during the last year.

Key company metrics

  • Open(U.S.) $15.59
  • Previous close(U.S.) $15.86
  • High(U.S.) $15.75
  • Low(U.S.) $14.72
  • Bid / Ask(U.S.) $14.96 / (U.S.) $15.15
  • YTD % change-75.35%
  • Volume6,338,193
  • Average volume (10-day)3,446,596
  • Average volume (1-month)5,865,095
  • Average volume (3-month)6,294,391
  • 52-week range(U.S.) $12.56 to (U.S.) $63.71
  • Beta0.61
  • Trailing P/E6.11×
  • P/E 1 year forward3.44×
  • Forward PEG2.72×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.47
Updated December 7 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.74%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue8849219641,074
Total other revenue--------
Total revenue8849219641,074
Gross profit327289275264
Total cost of revenue557632689810
Total operating expense9209691,0561,303
Selling / general / administrative187193178212
Research & development45514244
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)13193147237
Other operating expenses, total--------
Operating income-36-48-93-229
Interest income (expense), net non-operating-113-113-117-125
Gain (loss) on sale of assets--------
Other--------
Income before tax-145-165-207-353
Income after tax-191390-89444
Income tax, total46-555-119-797
Net income-219344-134-118
Total adjustments to net income--------
Net income before extra. items-191390-89444
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-191390-89444
Inc. avail. to common incl. extra. items-219344-134-118
Diluted net income-219344-134-118
Dilution adjustment--------
Diluted weighted average shares223223222224
Diluted EPS excluding extraordinary itemsvalue per share-0.861.75-0.401.98
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.482.020.033.03